Cargando…

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series

Detalles Bibliográficos
Autores principales:	Koschitzky, Merav, Tan, Kathryn, Noliza Encarnacion, Maria Rosa, Rivera-Oyola, Ryan, Khattri, Saakshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058610/ https://www.ncbi.nlm.nih.gov/pubmed/33898680 http://dx.doi.org/10.1016/j.jdcr.2021.03.006

Ejemplares similares

Apremilast as a treatment for morphea: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
por: Salna, Michael P., et al.
Publicado: (2017)

Eczematous eruption after guselkumab treatment for psoriasis
por: Reyn, Birgit, et al.
Publicado: (2019)

Pediatric COVID toes and fingers
por: Koschitzky, Merav, et al.
Publicado: (2021)

Eczematous reaction to IVIG for the treatment of dermatomyositis()()
por: Berk-Krauss, J., et al.
Publicado: (2018)

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018)

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
por: Luo, Nana, et al.
Publicado: (2022)

Dermatologic findings in 2 patients with COVID-19
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Dupilumab in HIV-positive patients: A case series report of 4 patients
por: Alawadhi, Ameen, et al.
Publicado: (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Should biologics for psoriasis be interrupted in the era of COVID-19?
por: Lebwohl, Mark, et al.
Publicado: (2020)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
por: Chen, Jiaoquan, et al.
Publicado: (2023)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
por: Edmonds, Nicole, et al.
Publicado: (2021)

Treatment of paradoxical eczematous eruption in psoriasis treated with secukinumab: A case report
por: Xiao, Yu, et al.
Publicado: (2023)

An Eczematous Eruption on the Arm
por: Sugita, Kazunari, et al.
Publicado: (2021)

Dupilumab for the treatment of severe photodermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
por: Brunner, P.M., et al.
Publicado: (2021)

Extensive Cutaneous Larva Migrans with Eczematous Reaction on Atypical Localization
por: Comparin, Cristiane, et al.
Publicado: (2016)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
por: Jay, Ryan, et al.
Publicado: (2022)

The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
por: Suresh, Raagini, et al.
Publicado: (2018)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023)

Eczematous skin lesion with nipple destruction
por: Inamadar, Arun C.
Publicado: (2012)

Persistent Eczematous Lesions Over the Body
por: Bhat, Ramesh M, et al.
Publicado: (2014)

Foot Disorders and Resistant Eczematous Ringworm
Publicado: (1935)

Tozinameran: Eczematous erythroderma: case report
Publicado: (2022)

Eczematous Reactions Induced by Anti-IL17 Agents: Report of Two Cases and Possible Pathogenic Mechanisms
por: Sánchez-Velázquez, Alba, et al.
Publicado: (2022)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021)

A case series of early biologic therapy in guttate psoriasis: Targeting resident memory T cell activity as a potential novel therapeutic modality
por: Flora, Akshay, et al.
Publicado: (2022)

Tozinameran: Severe eczematous eruption: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ur7lenk37q4o58jpmkk1hqcjq5